| 000 | 01719 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517150811.0 | ||
| 264 | 0 | _c20180702 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1938-0682 | ||
| 024 | 7 |
_a10.1016/j.clgc.2017.03.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Velasco, Guillermo | |
| 245 | 0 | 0 |
_aComprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials. _h[electronic resource] |
| 260 |
_bClinical genitourinary cancer _c12 2017 |
||
| 300 |
_a652-660.e1 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAngiotensin Receptor Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xpathology |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Neoplasms _xpathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNephrectomy _xmethods |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMcKay, Rana R | |
| 700 | 1 | _aLin, Xun | |
| 700 | 1 | _aMoreira, Raphel B | |
| 700 | 1 | _aSimantov, Ronit | |
| 700 | 1 | _aChoueiri, Toni K | |
| 773 | 0 |
_tClinical genitourinary cancer _gvol. 15 _gno. 6 _gp. 652-660.e1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clgc.2017.03.004 _zAvailable from publisher's website |
| 999 |
_c27082397 _d27082397 |
||